Ava is a patented multi-sensor bracelet, which allows women to precisely and conveniently predict fertile days.
Ava makes it easy to gain a profound and accurate understanding of your cycle and health—empowering you to make informed choices for your life.
Ava was founded in 2014 by Pascal Koenig, Lea Von Bidder, Philipp Tholen, & Peter Stein. The company is based in Zurich with additional offices in San Francisco. Makati and Belgrade.
Ava’s mission is to advance women’s reproductive health by bringing together artificial intelligence and clinical research.
Ava aims to be a long-term companion for women, providing data-driven and scientifically proven insights along all stages of their reproductive lives.
Ava's initial product consists of a sophisticated sensor bracelet, an app and a powerful backend with self-learning algorithms for interpretation of hormonal changes, accurate ovulation tracking and screening of women's health issues. Ava's technology has been validated in several clinical trials.
Ava is backed by btov Partners, SVC, Polytech Ventures, & Swisscom Ventures among others. The company raised $30M in it's most recent funding of a "Series B" round on May 30, 2018. This brings Ava's total funding to $42.4M to-date.